Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: A view from the blood-brain barrier

Neuroscience

Volumn 93, Issue 4, 1999, Pages 1449-1464

  Nadeau, S ^a   Rivest, S ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Blood vessels; Corticotroph axis; Cytokines; Inflammation; Lipopolysaccharide; Septic shock

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN C FOS; PROTEIN P55; PROTEIN P75; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN NUCLEUS; CAPILLARY ENDOTHELIUM; CELLULAR DISTRIBUTION; CHOROID PLEXUS; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; EPENDYMA; GENE EXPRESSION; GENETIC TRANSCRIPTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRAVENOUS DRUG ADMINISTRATION; LEPTOMENINX; MALE; MEDULLA OBLONGATA; MICROVASCULATURE; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; SOLITARY TRACT NUCLEUS; STRIA TERMINALIS; THALAMUS MIDLINE NUCLEUS;

ANIMALS; ANTIGENS, CD; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; ENCEPHALITIS; GENE EXPRESSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IN SITU HYBRIDIZATION; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MALE; NEURONS; PITUITARY-ADRENAL SYSTEM; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT PROTEINS; RNA, MESSENGER; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032765358     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00225-0     Document Type: Article

References (43)

1. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). Fedn Proc. Fedn Am. Socs exp. Biol. 4:1990;2860-2867.
2. Andersson J., Nagy S., Björk L., Abrams J., Holm S., Andersson U. Bacterial toxin-induced cytokine production studied at the single-cell level. Immun. Rev. 127:1992;69-96.
3. Bebo B.F. Jr, Linthicum D.S. Expression of mRNA for 55-kDa and 75-kDa tumor necrosis factor (TNF) receptors in mouse cerebrovascular endothelium: effects of interleukin-1 beta, interferon-gamma and TNF-alpha on cultured cells. J. Neuroimmun. 62:1995;161-167.
4. Bemelmans M.H., Gouma D.J., Buurman W.A. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma. J. Immun. 151:1993;5554-5562.
5. Bernardini R., Kamilaris T.C., Calogero A.E., Johnson E.O., Gomez M.T., Gold P.W., Chrousos G.P. Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology. 126:1990;2876-2881.
6. Beutler B., Cerami A. The biology of cachectin/TNF-α primary mediator of the host response. A. Rev. Immun. 7:1989;625-655.
7. Brady L., Lynn A.B., Herkenham M., Gottesfeld Z. Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J. Neurosci. 14:1994;4951-4964.
8. Crofford L.J., Tan B., McCarthy C.J., Hla T. Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arth. Rheum. 40:1997;226-236.
9. Elmquist J.K., Scammell T.E., Saper C.B. Mechanisms of CNS response to systemic immune challenge: the febrile response. Trends Neurosci. 20:1997;565-570.
10. Ericsson A., Kovács K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14:1994;897-913.
11. Fong Y., Tracey K.J., Moldawer L.L., Hesse D.G., Manogue K.B., Kenney J.S., Lee A.T., Kuo G.C., Allison A.C., Lowry S.F., et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J. exp. Med. 170:1989;1627-1633.
12. Grell M., Douni E., Wajant H., Lohden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83:1995;793-802.
13. Kalthoff H., Roeder C., Brockhaus M., Thiele H.G., Schmiegel W. Tumor necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor alpha and epidermal growth factor receptor mRNA. J. biol. Chem. 268:1993;2762-2766.
14. Kovacs K.J., Elenkov I.J. Diffencial dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus. J. Neuroendocr. 7:1995;15-23.
15. Kriegler M., Perez C., DeFay K., Albert I., Lu S.D. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell. 53:1988;45-53.
16. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J. Neurochem. 70:1998;452-466.
17. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitor factor kappa B alpha within specific cellular populations of the rat brain. J. Neurochem. 73:1999;309-321.
18. Lewis M., Tartaglia L.A., Lee A., Bennett G.L., Rice G.C., Wong G.H., Chen E.Y., Goeddel D.V. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. natn. Acad. Sci. U.S.A. 88:1991;2830-2834.
19. Mackay F., Loetscher H., Stueber D., Gehr G., Lesslauer W. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. exp. Med. 177:1993;1277-1286.
20. Marino M.W., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E., Jungbluth A., Wada H., Moore M., Williamson B., Basu S., Old L.J. Characterization of tumor necrosis factor-deficient mice. Proc. natn. Acad. Sci. U.S.A. 94:1997;8093-8098.
21. Milenkovic L., Rettori V., Snyder G.D., Beutler B., McCann S.M. Cachectin alters anterior pituitary hormone release by a direct action in vitro. Proc. natn. Acad. Sci. U.S.A. 86:1989;2418-2422.
22. Nadeau S., Rivest S. Regulation of the gene encoding tumor necrosis factor alpha in the rat brain and pituitary in response to different models of systemic immune challenge. J. Neuropath. exp. Neurol. 58:1999;61-77.
23. Natoli G., Costanzo A., Moretti F., Fulco M., Balsano C., Levrero M. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase. J. biol. Chem. 272:1997;26,079-26,082.
24. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P.S., Kronke M., Mak T.W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:1993;457-467.
25. Riches D.W., Chan E.D., Zahradka E.A., Winston B.W., Remigio L.K., Lake F.R. Cooperative signaling by tumor necrosis factor receptors CD120a (p55) and CD120b (p75) in the expression of nitric oxide and inducible nitric oxide synthase by mouse macrophages. J. biol. Chem. 273:1998;22,800-22,806.
26. Rothe M., Wong S.C., Henzel W.J., Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:1994;681-692.
27. Schall T.J., Lewis M., Koller K.J., Lee A., Rice G.C., Wong G.H., Gatanaga T., Granger G.A., Lentz R., Raab H., et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell. 61:1990;361-370.
28. Schmedtje J.F. Jr, Ji Y.S., Liu W.L., DuBois R.N., Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. biol. Chem. 272:1997;601-608.
29. Sharp B.M., Matta S.G., Peterson P.K., Newton R., Chao C., McAllen K. Tumor necrosis factor-alpha is a potent ACTH secretagogue: comparison to interleukin-1β Endocrinology. 124:1989;3131-3133.
30. Simmons D.M., Arriza J.L., Swanson L.W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radio-labeled single-stranded RNA probes. J. Histotechnol. 12:1989;169-181.
31. Smith C.A., Davis T., Anderson D., Solam L., Beckmann M.P., Jerzy R., Dower S.K., Cosman D., Goodwin R.G. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science. 248:1990;1019-1023.
32. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:1994;959-962.
33. Sorli C.H., Zhang H.J., Armstrong M.B., Rajotte R.V., Maclouf J., Robertson R.P. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc. natn. Acad. Sci. U.S.A. 95:1998;1788-1793.
34. Swanson L. W. (1992) Brain Maps: Structure of the Rat Brain. Elsevier, New York.
35. Tartaglia L.A., Ayres T.M., Wong G.H., Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:1993;845-853.
36. Tartaglia L.A., Goeddel D.V. Two TNF receptors. Immun. Today. 13:1992;151-153.
37. Tartaglia L.A. Jr, Goeddel D.V., Reynolds C., Figari I.S., Weber R.F., Fendly B.M., Palladino M.A. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immun. 151:1993;4637-4641.
38. Tartaglia L.A., Pennica D., Goeddel D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. biol. Chem. 268:1993;15,848-18,542.
39. Tsagarakis S., Gillies G., Rees L.H., Besser M., Grossman A. Interleukin-1 directly stimulates the release of corticotrophin-releasing factor from rat hypothalamus. Neuroendocrinology. 49:1989;98-101.
40. Vallières L., Lacroix S., Rivest S. Influence of interleukin-6 on neural activity and transcription of the gene encoding corticotropin-releasing factor in the rat brain: an effect depending upon the route of administration. Eur. J. Neurosci. 9:1997;1461-1472.
41. Vallières L., Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β J. Neurochem. 69:1997;1668-1683.
42. VanderMeer M.J., Hermus A.R., Pesman G.J., Sweep C.G. Effects of cytokines on pituitary beta-endorphin and adrenal corticosterone release in vitro. Cytokine. 8:1996;238-247.
43. 2 receptors in the rat brain: functional circuitry mediating the neuronal activation in response to systemic inflammation. Eur. J. Neurosci. (in press).